![]() 002004 3 Jun 2024 | Other | ¥0.22 Per Share |
![]() 002004 15 Jun 2023 | Other | ¥0.22 Per Share |
![]() 002004 2 Jun 2022 | Other | ¥0.22 Per Share |
![]() 002004 30 Apr 2021 | Other | ¥0.22 Per Share |
![]() 002004 19 Jun 2020 | Other | ¥0.22 Per Share |
23 May 2025 Date | | - Cons. EPS | 0.09 EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.07 EPS |
31 Aug 2024 Date | | - Cons. EPS | 0.08 EPS |
23 May 2024 Date | | - Cons. EPS | 0.08 EPS |
31 Oct 2023 Date | | - Cons. EPS | 0.06 EPS |
![]() 002004 3 Jun 2024 | Other | ¥0.22 Per Share |
![]() 002004 15 Jun 2023 | Other | ¥0.22 Per Share |
![]() 002004 2 Jun 2022 | Other | ¥0.22 Per Share |
![]() 002004 30 Apr 2021 | Other | ¥0.22 Per Share |
![]() 002004 19 Jun 2020 | Other | ¥0.22 Per Share |
23 May 2025 Date | | - Cons. EPS | 0.09 EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.07 EPS |
31 Aug 2024 Date | | - Cons. EPS | 0.08 EPS |
23 May 2024 Date | | - Cons. EPS | 0.08 EPS |
31 Oct 2023 Date | | - Cons. EPS | 0.06 EPS |
Agricultural Inputs Industry | Basic Materials Sector | Mr. Hai An Zhang CEO | XSHE Exchange | CNE000001JJ6 ISIN |
CN Country | 12,572 Employees | - Last Dividend | 27 May 2015 Last Split | 7 Jun 2004 IPO Date |
Huapont Life Sciences Co., Ltd., founded in 1992 and headquartered in Chongqing, China, is a multifaceted enterprise operating globally. Initially known as Huapont-Nutrichem Co., Ltd., the company underwent a rebranding in September 2015 to better reflect its expanded focus in the life sciences sector. Its business scope spans across several domains including medicine, medical care, agrochemicals, new materials, tourism, and other diversified activities. With a strong emphasis on the production and sale of pharmaceutical preparations and raw materials, Huapont Life Sciences has established itself as a significant player in China's pharmaceutical and agrochemical industries, offering a wide array of products and services tailored to meet the demands of its global clientele.
At the heart of its product lineup, the company specializes in the manufacturing and distribution of pharmaceutical preparations and raw materials. These products are essential components for the production of various medicines, catering to a wide range of therapeutic categories.
Huapont Life Sciences' pharmaceutical range includes medicines for skin conditions, tuberculosis, anti-infection, respiratory issues, anti-tumor treatments, and ophthalmology. The company emphasizes the development of medications that address critical health areas, thereby improving patient outcomes.
Offering solutions beyond pharmaceuticals, Huapont also ventures into health management products. These are designed to support overall well-being and preventive healthcare, reflecting the company's commitment to fostering healthier lives.
In the agrochemical field, Huapont provides pesticide technical products, intermediates, and preparations. These products play a crucial role in crop protection and yield enhancement, serving the agricultural sector with solutions grounded in scientific research.
The company offers Good Laboratory Practice (GLP) registration technical services, assisting in the compliance and regulatory approval process for agrochemical products. This service ensures clients navigate the complexities of product registration efficiently.
Huapont extends its expertise to the research, development, production, and sales of fine chemical products and polymer materials. These high-quality materials find applications in various industries, showcasing the company’s ability to innovate and diversify.
Expanding beyond its core activities, Huapont also enters the tourism industry, providing services that enrich travel experiences. This venture illustrates the company's strategy to explore new business areas and offer comprehensive lifestyle solutions.
Additionally, Huapont acts as an agent for the promotion of preparation products, facilitating market access and visibility for pharmaceutical products. This aspect of the company's operation underscores its integrated approach in the healthcare and pharmaceutical industries.